Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment.
BACKGROUND: The contribution of aberrant DNA methylation in silencing of tumor suppressor genes (TSGs) and microRNAs has been investigated. Since these epigenetic alterations are reversible, it became of interest to determine the effects of the 5-aza-2'-deoxycytidine (DAC) demethylation therapy...
Main Authors: | Ramin Radpour, Zeinab Barekati, Corina Kohler, Martin M Schumacher, Thomas Grussenmeyer, Paul Jenoe, Nicole Hartmann, Suzette Moes, Martin Letzkus, Johannes Bitzer, Ivan Lefkovits, Frank Staedtler, Xiao Yan Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3208622?pdf=render |
Similar Items
-
Specificity of Methylation Assays in Cancer Research: A Guideline for Designing Primers and Probes
by: Zeinab Barekati, et al.
Published: (2010-01-01) -
Epigenetic reprogramming and DNA demethylation
by: Bagci, Hakan
Published: (2014) -
Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors
by: Diesch Claude, et al.
Published: (2009-11-01) -
Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer.
by: Ramin Radpour, et al.
Published: (2011-01-01) -
Epigenetic Regulation of Adipogenic Differentiation by Histone Lysine Demethylation
by: Geovanny I. Nic-Can, et al.
Published: (2019-08-01)